Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

2(66.7%)

N/A

1(33.3%)

3Total

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07562243Not Yet Recruiting

Project PHOENIX: Molecular Signatures of Burn Pit Exposure

Role: collaborator

NCT07227194Completed

Machine Learning Assessment of Next-Day Migraine Likelihood

Role: collaborator

NCT06134232Phase 2Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Role: collaborator

NCT06810726Phase 2Recruiting

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

Role: collaborator

NCT00291525Not ApplicableCompleted

Randomized On-X Anticoagulation Trial

Role: collaborator

All 5 trials loaded